Clinical Trials Browser

Recruiting × Multiple Myeloma × Hyaluronoglucosaminidase × Clear all

NCT06622005 2026-04-21

SX-682 in Combination With Carfilzomib, Daratumumab-Hyaluronidase, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Phase 1 Recruiting

Multiple Myeloma